TEXAS ENGINEERING EXPERIMENT STATION
COLLEGE STATION, TX
What changed
Study registered, no phase assigned: Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function
9mo agoTrial registeredOct 1, 2025Source filing (opens the source filing in a new tab)
Momentum
Momentum 89 out of 100, unchanged since the last recompute.
Accelerating: several high-weight events landed recently.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Grant-only
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Peer position
10,939 pre-ticker oncology companies at Grant-only
Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.
Compare seatsA ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Grant
R01 · $617k · non-dilutive
Sep 1, 2023TEXAS ENGINEERING EXPERIMENT STATION · PI MCSHANE, MIKE · NIDDK · award ends Aug 31, 2028 · Minimally-invasive technology for personalized nutritional monitoring
NIH RePORTER · NIH RePORTER 11182728 (opens the source filing in a new tab)
- Trial
NA registered
Feb 2, 2021OSA, Covid19, Residual Symptoms of COVID 19, COPD · COMPLETED · sponsor: Texas A&M University · COPD Circuit Exercise
ClinicalTrials.gov · NCT05395390 (opens the source filing in a new tab)
- Trial
NA registered
May 30, 2019Type 2 Diabetes · COMPLETED · sponsor: Texas A&M University · Isoleucine Intake and Intermediary Metabolism in Type 2 Diabetes
ClinicalTrials.gov · NCT04461236 (opens the source filing in a new tab)
- Trial
NA registered
Oct 20, 2017Obstructive Pulmonary Disease, Exacerbation Copd · COMPLETED · sponsor: Texas A&M University · AECOPD and Nutritional Supplementation in COPD
ClinicalTrials.gov · NCT06801964 (opens the source filing in a new tab)
- Trial
NA registered
Apr 19, 2017Chronic Obstructive Pulmonary Disease · COMPLETED · sponsor: Texas A&M University · Short Chain Fatty Acid Metabolism in COPD
ClinicalTrials.gov · NCT03327181 (opens the source filing in a new tab)
- Trial
NA registered
Feb 10, 2016Pulmonary Disease, Chronic Obstructive, Congestive Heart Failure · COMPLETED · sponsor: Texas A&M University · CHF COPD Sip Feed Anabolic Response
ClinicalTrials.gov · NCT02770092 (opens the source filing in a new tab)
- Trial
NA registered
Apr 2, 2014Mild Cognitive Impairment · COMPLETED · sponsor: Texas A&M University · Effects of Alpha-lactalbumin Intake on Metabolic and Cognitive Functions in Elderly
ClinicalTrials.gov · NCT02082418 (opens the source filing in a new tab)
- Trial
NA registered
Nov 15, 2010Cystic Fibrosis · COMPLETED · sponsor: Texas A&M University · Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function
ClinicalTrials.gov · NCT01494909 (opens the source filing in a new tab)
- Trial
NA registered
Sep 8, 2009Chronic Obstructive Pulmonary Disease · COMPLETED · sponsor: Texas A&M University · EAA Intake to Optimize Protein Anabolism in COPD
ClinicalTrials.gov · NCT01173354 (opens the source filing in a new tab)
- Trial
NA registered
Aug 18, 2009Protein Metabolism · COMPLETED · sponsor: Texas A&M University · Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to Surgery
ClinicalTrials.gov · NCT00497380 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources